Clemens Jilek

Clemens Jilek

Auto-generated profile, based on publicly available information

Clemens Jilek

Peter-Osypka Heart Centre Munich, Internistisches Klinikum München Süd, 81379 Munich, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
CJClemens Jilek
Clemens Jilek
MKMarion Krenn
Marion Krenn
DSDaniela Sebah
Daniela Sebah
RORuth Obermeier
Ruth Obermeier
ABAstrid Braune
Astrid Braune
MAMichael Arzt
Michael Arzt
Aims: Sleep disordered breathing (SDB) may contribute to disease progression in patients with chronic heart failure (CHF). The objective of this observational study was to evaluate whether SDB is a risk factor for mortality in CHF patients and whether this risk can be attenuated by treatment with positive airway pressure (PAP). Methods and results: We studied 296 CHF patients (median left ventricular ejection fraction 33%) who underwent in-lab polysomnography between January 2002 and December 2009. We compared (i) mortality between patients with severe SDB [apnoea–hypopnoea index (AHI) ≥ 22.5 h−1] vs. those without severe SDB (AHI < 22.5 h−1) and (ii) evaluated the impact of PAP treatment on mortality in those with severe SDB. After accounting for significant confounding factors (age, NYHA class, cause of CHF, diabetes, and PAP treatment), patients with severe SDB (n= 176) had a 2.0-fold increased hazard ratio for death compared with those without severe SDB [95% confidence interval (CI) 1.1–3.5, P= 0.023]. In an adjusted on-treatment analysis of the group with severe SDB, mortality was significantly less in patients using PAP (18%) compared with those with untreated SDB (52%; hazard ratio 0.4, 95% CI 0.2–0.6, P= 0.001). Mortality in the PAP-treated group was lower compared with the untreated group at any time-point of the follow-up period. Conclusion: The presence of severe SDB in CHF patients constitutes a significantly increased risk for death, independent of established risk factors. In CHF patients with SDB, use of PAP therapy was associated with a decreased mortality rate at any time point of the follow-up, suggesting that PAP can be safely used in such patients.

30 November 2010 in Circulation
Verified
Journal Article
Closed access
PDF file
IDIsabel Deisenhofer
Isabel Deisenhofer
BZBernhard Zrenner
Bernhard Zrenner
YYYue-Hui Yin
Yue-Hui Yin
HPHeinz-Friedrich Pitschner
Heinz-Friedrich Pitschner
MKMalte Kuniss
Malte Kuniss
GHGabriele Hessling
Gabriele Hessling
Background—: Cryoablation has emerged as an alternative to radiofrequency catheter ablation (RFCA) for the treatment of atrioventricular (AV) nodal reentrant tachycardia (AVNRT). The purpose of this prospective randomized study was to test whether cryoablation is as effective as RFCA during both short-term and long-term follow-up with a lower risk of permanent AV block. Methods and Results—: A total of 509 patients underwent slow pathway cryoablation (n=251) or RFCA (n=258). The primary end point was immediate ablation failure, permanent AV block, and AVNRT recurrence during a 6-month follow-up. Secondary end points included procedural parameters, device functionality, and pain perception. Significantly more patients in the cryoablation group than the RFCA group reached the primary end point (12.6% versus 6.3%; P =0.018). Whereas immediate ablation success (96.8% versus 98.4%) and occurrence of permanent AV block (0% versus 0.4%) did not differ, AVNRT recurrence was significantly more frequent in the cryoablation group (9.4% versus 4.4%; P =0.029). In the cryoablation group, procedure duration was longer (138±54 versus 123±48 minutes; P =0.0012) and more device problems occurred (13 versus 2 patients; P =0.033). Pain perception was lower in the cryoablation group ( P <0.001). Conclusions—: Cryoablation for AVNRT is as effective as RFCA over the short term but is associated with a higher recurrence rate at the 6-month follow-up. The risk of permanent AV block does not differ significantly between cryoablation and RFCA. The potential benefits of cryoenergy relative to ablation safety and pain perception are counterbalanced by longer procedure times, more device problems, and a high recurrence rate. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00196222.

14 May 2009 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
RWR. Wensel
R. Wensel
CJC. Jilek
C. Jilek
MDM. Dörr
M. Dörr
DFD. P. Francis
D. P. Francis
HSH. Stadler
H. Stadler
RER. Ewert
R. Ewert
Pulmonary arterial hypertension (PAH) results in chronic right heart failure, which is associated with an increase in sympathetic tone. This may adversely affect cardiac autonomic control. We investigated the changes in cardiac autonomic nervous activity in relation to disease severity in patients with PAH.In 48 patients with PAH (median World Health Organization class III, pulmonary artery pressure 52±14 mmHg, pulmonary vascular resistance 1,202±718 dyn·s·cm−5, cardiac index 2.0±0.8 L·min−1·m−2) and 41 controls, cardiac autonomic nervous activity was evaluated by measurement of heart rate variability (HRV) and baroreflex sensitivity. All patients underwent cardiopulmonary exercise testing (peak oxygen uptake 13.2±5.1 mL·kg−1·min−1, minute ventilation/carbon dioxide production slope 47±16).In patients with PAH, spectral power of HRV was reduced in the high-frequency (239±64versus563±167 ms2), low-frequency (245±58versus599±219 ms2) and very low-frequency bands (510±149versus1106±598 ms2; all p<0.05). Baroreflex sensitivity was also blunted (5.8±0.6versus13.9±1.2 ms·mmHg−1; p<0.01). The reduction in high-frequency (r = 0.3, p = 0.04) and low-frequency (r = 0.33, p = 0.02) spectral power and baroreflex sensitivity (r = 0.46, p<0.01) was related to the reduction in peak oxygen uptake.Patients with PAH have a marked alteration in cardiac autonomic control that is related to exercise capacity and may, therefore, serve as an additional marker of disease severity.

1 November 2012 in Journal Of Hypertension
Verified
Journal Article
Closed access
KSKristin Steigerwald
Kristin Steigerwald
ATAnna Titova
Anna Titova
CMCaroline Malle
Caroline Malle
EKElisabeth Kennerknecht
Elisabeth Kennerknecht
CJClemens Jilek
Clemens Jilek
MJMichael Joner
Michael Joner
Objectives: Catheter-based renal artery denervation has been successfully introduced as alternative treatment for patients suffering from drug-resistant essential hypertension. However, the local morphological changes within the vessel wall accompanying this technique remain elusive and we sought to characterize these by utilizing the simplicity radiofrequency catheter approach. Methods: Following treatment of seven pigs, renal arteries were assigned to either the acute (n = 6), subacute (10-day follow-up, n = 6) or control (untreated, n = 2) group. At follow-up blood analysis, final angiography and optical coherence tomography (OCT)-imaging of the treated arteries were performed and renal arteries and kidneys were processed for histopathology and immunohistochemistry. Results: Radiofrequency-derived energy application to the vessel wall induced transmural tissue coagulation and loss of endothelium resulting in local thrombus formation also detectable by OCT. At 10 days, the luminal surface was almost completely re-endothelialized. Mural wall damage was replaced by fibrotic tissue and the adventitial layer showed strong inflammatory infiltration including vasculogenesis. Remnant autonomic nerve fascicles within the lesion segments of the subacute group displayed enhanced vacuolic degeneration and an impaired neurofilament protein immunostaining pattern. Examination of the kidneys revealed no abnormalities and blood parameters remained within the physiological range. Conclusion: Catheter-based application of radiofrequency energy resulted in circumscribed transmural injury within the arterial wall affecting autonomic nerve fascicles delayed to treatment. Acute loss of endothelialization resulted in thrombus formation leaving kidney perfusion apparently unimpaired.

6 October 2009 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
SFSabine Fredersdorf
Sabine Fredersdorf
SWStefan Weber
Stefan Weber
CJClemens Jilek
Clemens Jilek
NHNorbert Heinicke
Norbert Heinicke
CBChristian VON Bary
Christian VON Bary
AJAndreas Jeron
Andreas Jeron

17 May 2010 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
STStylianos Tzeis
Stylianos Tzeis
ALArmin Luik
Armin Luik
CJClemens Jilek
Clemens Jilek
CSClaus Schmitt
Claus Schmitt
HEHeidi L. Estner
Heidi L. Estner
IDIsabel Deisenhofer
Isabel Deisenhofer